SENJU Pharmaceutical Home Page.We intend to continue building on the trust placed in us by the medical community by contributing to a better future for all.
Total Certificate of Past Records, 2-5-8, Hirano-machi, Chuo-ku, Osaka Senju Pharmaceutical Co.,Ltd. Company, Corporation, Others No.:1299-01- 082721.
... Sitemap · Japanese Site · 中文 · About Senju; Overseas Activities; Products; Research&Development; News. Home · Research & Development; R&D Pipeline ...
At senju Pharmaceutical, we take an open-minded approach to research and development, preferring innovation to conventional solutions. By remaining flexible ...
Senju Pharmaceutical Co. Ltd. manufactures and distributes pharmaceutical products. The Company produces prescription drugs, over the counter medicines , animal drugs, and other products. Senju Pharmaceutical also produces eye drops, contact lens cleaners, and other products.
Industry; Pharmaceuticals. OTC, Consumer. Therapeutic Areas; Immune Disorders; Inflammation; Ophthalmic; Alias(es); Ownership; Private; Headquarters; Worldwide. Asia. Pacific Rim. Japan. Parent & Subsidiaries; Senju Pharmaceutical Co. Ltd. Senior Management; Yukoh Yoshida, Pres. & CEO Takashi Sugisawa, Exec.
Learn about working at Senju Pharmaceutical Co., Ltd.. Join LinkedIn today for free. See who you know at Senju Pharmaceutical Co., Ltd., leverage your professional network, and get hired.
Mar 20, 2015 ... SENJU PHARMACEUTICAL CO., Ltd., Kyorin Pharmaceutical Co., Ltd., Allergan, Inc., Plaintiffs–Appellants v. LUPIN LIMITED, Lupin Pharmaceuticals, Inc., Defendants–Appellees. Hi–Tech Pharmacal Co., Inc., Defendant–Appellee.
The double-blind, U.S. Phase IIb DEL MAR trial in 136 DME patients showed that once-monthly 1 mg Luminate met the primary endpoint of non-inferiority to Avastin bevacizumab in the mean improvement from baseline in BCVA... Read More. j0, Oct 10, 2016 | BC Week In Review | Clinical News | Clinical Status ...